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3. Abstract 
Music is universal and ubiquitous across human cultures. Music 
perception and performance form a useful tool for studying the normal 
functioning of the human brain. The abundance of a neuroscientific 
literature has demonstrated that music perception and performance alters 
the human brain structure and function and induces physiological changes 
through neurochemical modulation. More recently, molecular genetic 
approaches have been applied to study music-related phenotypes. 
Emerging evidence from candidate gene studies and genome-wide linkage 
and association studies have suggested a substantial genetic component in 
musical aptitude and related traits like creativity in music. The associated 
loci contain candidate genes that are responsible for the development of 
the inner ear, auditory pathway and neurocognition. 
This thesis puts a step forward in understanding the molecular genetic 
background of music perception and performance, using a combination of 
genomics and bioinformatics approaches. Specifically, the role of copy 
number variations (CNVs; a form of genetic variation) in musical aptitude 
and creativity in music was investigated both in the largest families of the 
MUSGEN-project and also in sporadic cases. The effect of music 
perception on human transcriptional responses was studied by listening to 
classical music. Also, the effect of music performance on human RNA 
profiles of professional musicians was investigated.  
We identified a population-specific enrichment and depletion of certain 
copy number variable regions (CNVRs) that demonstrated a founder 
effect in the population isolate of Finland. Intrigued by the enrichment of 
certain CNVRs, we inspected whether the enriched CNVRs affect musical 
phenotypes using a phenotype mining-like approach. Although we found 
no significant hits because of the less powered sample set, the enrichment 
of genes like galactose mutarotase (GALM) and cGMP dependent protein 
kinase type 1 (PRKG1) is quite interesting because of their relevance for 
serotoninergic pathways and long-term potentiation that are related to 
music perception. Above all, the study presented a unique resource of 
CNV map from the isolated Finnish population, which has been 
unavailable so far for the evaluation of the role of CNVs in complex 
diseases and traits.  
The second study focused to elucidate the role of inherited and sporadic 
CNVs in musical aptitude and creativity in music. The genome-wide CNV 
analysis in five large multi-generational families and 172 unrelated 
individuals principally identified genes like GALM, PCDHA1-9 as the 
possible candidate genes that could affect musical aptitude and creativity 
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in music. PCDHA1-9 and GALM genes are known to regulate the 
serotonergic system, which is responsible for neurocognitive and motor 
functions, the essential biological processes of music related traits. 
Overall, the detected genes affect neurodevelopment, learning, memory 
and serotonergic functions. The findings also demonstrated that large and 
rare CNV burden does not affect normal traits like musical aptitude.  
Listening to music enhanced the activity of genes that are known to be 
involved in dopaminergic neurotransmission, synaptic plasticity, learning, 
and memory. Genes that are known to cause oxidative stress, deficits in 
dopaminergic neurotransmission, and neuronal apoptosis showed a 
diminished activity after music listening. Most importantly, the up-
regulated gene synuclein alpha (SNCA) and its upstream transcription 
regulator GATA2 are located on chromosomal regions 4q22.1 and 3q21 
respectively linking the strongest linkage and associated regions of 
musical aptitude together. Other up-regulated genes like NRGN, RGS2, 
FKBP8, and NPTN have been known to be responsible for cognitive 
functions like learning and memory, which are essential for music 
perceptive abilities. In addition, several of the up-regulated genes have 
been known to be regulated during song learning and singing in songbirds.   
Music performance enhanced the activity of genes that are known to be 
involved in dopaminergic neurotransmission, neuroplasticity and 
cognitive functions like learning and memory. Upregulated genes like 
SNCA, FOS, and DUSP1 have been known to be involved in song 
learning and singing in songbirds suggesting evolutionary conservation of 
these genes in vocal development. In addition, modulation of genes 
related to calcium ion homeostasis, iron ion homeostasis, and several 
neurodegenerative diseases suggest that music performance may affect the 
biological mechanisms that are essential for normal neuronal function and 
survival.  
To the best of our knowledge, these findings are novel. They give 
preliminary information about the genes associated with musical aptitude 
and the effect of music on the human body.  It is obvious that replication 
studies are required to confirm the results. The results can have 
implications in further studies on biological mechanisms of music and 
their relationship to human brain function.  The results may be utilized in 
studies on the molecular evolution of music, gene-environment interaction 
of musical traits and functional analyses of the identified genes. Some of 
those findings could explain the molecular mechanisms that contribute to 
the therapeutic effect of music.  
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4. Introduction 
Over the last two decades, substantial effort has been put into delineating 
the neurobiology of music perception and performance owing to two 
reasons: (1) Music perception and performance are complex cognitive 
functions and thus studying their neurobiology provides an opportunity to 
understand the function of normal brain, and (2) investigation of the 
biological basis of music perception and performance may elucidate the 
evolutionary functional origins of music and its biological value. Like 
language, music is universal to all human cultures. The technological 
advances in functional neuroimaging methods allowed the cognitive 
neuroscience field to perform systematic and sustainable studies to 
understand the biological basis of music perception and performance. 
Scientific evidences over the past decade have amply demonstrated that 
music performance and perception modulates specific regions of the brain 
and alters its structure and function 1–5.  
The development of genomic and bioinformatic approaches 6 have made it 
possible to study the genetic and biological basis of human cognitive 
traits.  These methods can be applied to study human traits based on their 
molecular properties rather than anatomic regions. The greatest benefit of 
genomic methods is that they enable the studies on biological phenomena 
using an unbiased and hypothesis-free approach, without any knowledge 
of the biological background of the phenotype. In addition, a more 
detailed analysis at the molecular level is possible.  Based on family and 
twin studies genetic component has been demonstrated in several musical 
traits, like congenital amusia, absolute pitch and musical aptitude 7–9. 
Recently, genome-wide linkage and association analyses have been 
performed in musical traits 10–13. These studies have found that musical 
aptitude is a multifactorial trait associated with several genetic loci and 
environmental factors.  There is evidence that not everyone who practices 
music becomes a professional musician 14, which suggests that music 
perception and performance in addition to exposure to music (education 
and training), requires certain innate qualities like predisposing genetic 
variants. Music is also a strong environmental trigger that affects 
emotions 15–17. 
This thesis attempts to utilize genomic and bioinformatic approaches to 
understand the molecular genetic background of music-related traits and 
practices. Specifically, the role of copy number variantions (CNVs) in 
music-related traits, as well as the effects of listening to music and 
performing music on human transcriptome was studied. 
  
  13 
5. Review of the literature 
5.1 Human genome and High-throughput bioinformatics 
5.1.1 Advent of the human genome project 
Sequencing the human genome is not a challenge anymore, rather 
understanding and using the generated data is. 
Two inventions of the late 1980s revolutionized human life; The Internet 
and the first automated DNA Sequencer. The former has profoundly 
affected several aspects of human life like business, communication and 
economy, whereas the latter has dramatically altered the fundamental 
knowledge of human biology and medicine. In 1987, the first automatic 
DNA sequencing method enabled the successful sequencing of murine 
cardiac muscarinic and beta-adrenergic receptor genes18. That success 
story provided ample encouragement and confidence for the inception of 
largest ever collaborative effort in biology: the Human Genome Project 
(HGP). Perpetual curiosity over human evolution and disease causation 
led to the consistent production of big data, ever since the release of the 
first draft of human genome 19,20.  On par with the discoveries of the 
atomic bomb, the periodic table, or even the moonshot, HGP has greatly 
influenced and opened new avenues of research in biomedicine 21. Human 
genetics research has drastically advanced at a rapid pace post-HGP 
(Table 1).  
Table 1: Quantitative advances since the Human Genome Project (HGP) 
 HGP 
begins 
1990 
HGP 
ends 
2003 
Decade 
after HGP 
2013 
No. of genes with known 
phenotype/Disease-causing mutation 
53 
 
1474 2972 
No. of phenotypes/disorders with 
known molecular basis 
61 2264 4847 
No. of published genome-wide 
association studies 
0 0 1542 
Replicated disease-associated genetic 
variants 
0 6 ~2900 
Drugs with pharmacogenomics 
information on label 
4 46 106 
Data has been obtained from public domain, (http://www.genome.gov/27553526) 
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Substantial efforts have been made to catalog the major portion of 
common genetic variation 22,23, and gene expression under various 
biological conditions 24–26. Multiple lines of investigation have been 
employed subsequently to understand the molecular genetic background 
of human diseases (both rare monogenic and complex) and continuous 
traits 27–32. Seemingly ceaseless production of large datasets necessitated 
the rise of computational biology 33,34. Nowadays genome-wide analyses, 
especially with exome sequencing are being initiated as a routine test as 
part of diagnostic testing in individuals with rare genetic disorders 35,36. 
Above all, genomics has enabled a comprehensive, unbiased, and 
hypothesis-free investigation of various biological phenomena 6. 
5.1.2 Structure of the human genome 
The first draft of human genome sequence and several other data sources 
suggested that any two individuals are 99.5% similar genetically. The 
remaining 0.5% genomic variation was thought to be the causative for all 
the phenotypic differences between any two individuals. Such genomic 
alterations could be either microscopic or sub-microscopic (Table 2)37. 
Early analyses of the human genome established SNPs to be the major 
source of genetic variation 38, where large collaborative efforts like the 
International HapMap project22 attempted to capture the major portion of 
the common genetic variation. The arrival of state-of-the-art genome 
scanning technologies in the mid-2000s revealed that other forms of 
structural alterations like CNVs contribute extensively to the genomic 
variation 39–41. Because of their large size spanning up to several 
megabases, CNVs affect the gene expression, thereby increasing the risk 
of disease susceptibility 42–45.  
 
Table 2: Classification of genomic alterations 
 Microscopic 
alterations 
Sub-microscopic 
alterations 
Size > 3 Mb < 3 Mb 
Under 
microscope 
Yes No 
Examples Aneuploidies  
Rearrangements  
Heteromorphisms 
Fragile sites 
SNPs 
Small inversions 
Deletions 
Insertions 
Duplications 
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5.1.3 Copy number variations 
Copy number variations are a form of submicroscopic genomic variation 
that include multiple genomic rearrangements such as deletions, 
duplications and insertions of DNA segments larger than one kilobase 
(Figure 1) 37,39–41. A CNV that appears in more than 1% of the population 
is referred to as a copy number polymorphism (CNP) 37. At least 100 
CNVs are expected to be present in every individual 46.  
 
Figure 1: An example of CNVs. Deletions or duplications of DNA sequence are 
referred to as CNVs. For example, if A-B-C-D represents the normal form of DNA 
sequence, both A-A-B-C-D (duplication of A) and B-C-D (deletion of A) represent 
CNVs. 
Non-allelic homologous recombination (a form of recombination that 
occurs between DNA sequences of high sequence similarity; NAHR) and 
non-homologous end-joining mechanisms are known to be the leading 
causes of the occurrence of CNVs 47. Nevertheless, perturbation of DNA 
replication and replication of non-contiguous DNA segments have also 
been shown to contribute to the formation of CNVs 48. 
CNVs represent the major portion of the variation in the human genome 
with respect to size and are known for their role in altering gene 
expression, thereby affecting genetic diversity, evolution, and disease risk 
44,49–57. An increasing number of genomic variants have been catalogued 
from normal individuals (Database of Genomic Variants, 
http://dgv.tcag.ca/dgv/app/home) that show both inter- and intra-
population differences 58–67.   Additionally, characterization of population-
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specific CNVs play a vital role in disease association studies 68,69. 
Nonetheless, integration of the identified CNVs is easier said than done 
because of the differences in the platforms, populations, computational 
methods and quality assessment measures 68.  The onset of massively 
parallel sequencing and the successful integration of experimental and 
computational approaches have exponentially increased the CNV 
detection rate. However, the comprehensive identification of CNVs would 
only be feasible with a cost-effective and high-quality de-novo assembly 
of human genomes 70. 
CNVs have not only extended our understanding of the concept of normal 
human variation, but also exemplified the importance of genomics in 
clinical settings of complex diseases and traits 71. Especially, rare CNVs 
have explained a substantial proportion of risk for schizophrenia, bipolar 
disorder, autism spectrum disorder and several other psychiatric diseases 
72. Thus, CNVs are increasingly being considered as therapeutic targets 
because of their detrimental role 73. Of late, the role of CNVs in more 
normal traits such as height, intelligence and diet consumption has also 
been investigated 74–77. In addition, emerging studies have established a 
crucial role for CNVs in human evolution and adaptation. CNVs have 
recently been shown to facilitate the creation of novel genes which 
respond to swift changes in environment 78.  
5.1.4 Complex traits 
Phenotypes that do not exhibit classic Mendelian inheritance pattern are 
often referred to as complex traits 79. Such complex traits are controlled by 
a combination of multiple genes and environmental factors, of which the 
majority remain unidentified 79,80. Several genes that act independently or 
together in a common biological pathway may cause a complex phenotype 
79. On the contrary, a single gene may affect several phenotypes, known as 
pleiotropy 81. For example, a recent genome-wide study revealed the risk 
loci that have shared effects across five major psychiatric disorders 82. 
Notably, genetic susceptibility alone does not necessarily lead to a 
complex phenotype 83.  
Environmental exposure and lifestyle are known to largely influence the 
development of complex phenotypes 80,83,84. To obtain a holistic view of 
the complex phenotypes, it is, therefore, necessary to employ a 
multifaceted approach that characterizes various forms of genomic 
variation and gene expression under distinct biological conditions (Figure 
2). The arrival of highly parallel genome-wide experiments using high-
throughput measurement techniques85 has enabled the accomplishment of 
such goals efficiently and economically.  
  17 
 
 
Figure 2: Complex phenotypes. Both genetic variation and environmental 
exposure influence the genes and functional elements to cause a disease or 
phenotype. 
5.1.5 DNA microarrays 
The old-fashioned low-throughput measurement techniques query 
individual genomic loci. Characterizing several genomic loci using such 
low-throughput methods often leads to high expenditure. That scenario 
changed in the mid-90s when a landmark study has shown that DNA 
could be hybridized onto microarrays 86. For example, one of the initial 
high-throughput studies has used microarrays to automate the 
hybridization of Arabidopsis thaliana cDNAs onto a glass slide 87. 
Microarrays are perhaps one of the first tools that have drastically 
changed the biological research since the mid-90s. The onset of 
microarray technology has dramatically transformed the genomic research 
towards global investigations of cellular activity. Although high-
throughput genome-wide measurements have originally been developed 
for high-throughput DNA mapping and sequencing, initially they have 
been more successful at transcript-level analyses. Subsequently, the scope 
of microarray applications have expanded in biological research, 
especially in areas such as genotyping, RNA quantification, splice variant 
analysis, DNA-structure analysis, CNVs, detection and characterization of 
protein binding sites and nucleotide modifications, epigenetic studies, 
DNA mapping and so on 88. 
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5.1.5.1 SNP arrays 
Single nucleotide polymorphisms (SNPs) are the most common and most 
studied form of genetic variations 22,23. A SNP refers to a genomic 
position, where two distinct alleles of significant proportion occur in the 
human population 37. The two alleles of a SNP are often referred to as 
alleles A and B. As each allele is inherited from one of the parents, the 
genotype of a SNP could be AA or BB or AB 89.  
The genotyping technologies have seen dramatic advancements in the last 
decade. Today the arrays are capable of assaying more than five million 
SNPs per array for SNP and CNV detection 90 whereas the first whole-
genome SNP array assayed approximately ten thousand SNPs91. SNP 
arrays have been contributing significantly to the detection and 
characterization of CNVs 39,40,92 and regions of homozygosity (ROHs) 93–96 
in addition to their remarkable contribution towards population genetic 
studies 97–100. The generic workflow of a SNP array is shown in Figure 3. 
 
Figure 3: The generic workflow of a SNP array. The single-stranded DNA 
sequence is usually fragmented, labeled and then hybridized onto the array, which 
contain probe sets for each allele of a SNP. After scanning the array, genotypes 
are determined based on the signal [either homozygous (AA or BB) or 
heterozygous AB].  
5.1.5.2 Gene expression microarrays 
Gene expression microarrays quantitate the messenger ribonucleic acid 
(mRNA) levels of the cells. These microarrays have gained much 
prominence after the successful expression profiling of 800 genes of the 
yeast cell cycle in 1998 101. In general, microarray studies are not a priori 
hypotheses-driven; rather they are performed to generate hypotheses. 
Examples of the early success of microarrays in medical research are from 
cancer studies, where microarrays have been successfully used to classify 
distinct cancer subtypes and clinical outcomes 102–104. The generic 
workflow of a gene expression microarray is similar to that of a SNP 
array, except for the use of mRNA probe sequences. 
An established standard exists for recording and reporting microarray-
based gene expression data 105. However, comparisons of distinct gene 
Genomic	  DNA	   Fragmentation	  Ampli3ication	  Labeling	   Hybridization	   Feature	  extraction	  In	  silico	  analysis	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expression studies require careful consideration of the factors that 
influence the biological signal. Firstly, several studies have earlier shown 
that technical variation (e.g, studies at different laboratories and using 
different platforms) has a very little effect on the biological signal when 
compared to effect of biological variation (biological samples and human 
factors) 106,107. Second, the selection of differentially expressed genes in 
microarray experiments is highly dependent on the fold-change threshold. 
A widespread and prevailing misconception suggests that only two-fold 
changes are significant 88. The basis for such a false notion stemmed from 
some of the pioneering microarray studies that used a two-fold change 
threshold for a specific set of experiments, owing to biological relevance. 
However, it is noteworthy that fold-change thresholds are absolutely 
arbitrary and they largely depend upon the underlying biological question.  
5.1.6 Microarrays and NGS 
The journey of the next-generation sequencing (NGS) technologies started 
with the arrival of the first next-generation sequencer in 2004 by Roche 
and is now heading towards a more advanced third-generation sequencing 
methods 108–112. Studies using NGS technologies have made significant 
contributions in the fields of genetics and genomics 6,113–115. Several 
studies have compared and described DNA microarrays and NGS as 
competing technologies 116–126, but emerging analyses suggest that they are 
rather complementary technologies127–129. Although NGS is increasingly 
outperforming microarrays in terms of robustness and sensitivity, 
microarrays still remain useful for measuring known targets in large 
samples. However, the choice of platform for genome analysis essentially 
depends on research objective, required throughput, available budget and 
data analysis methods 129,130.   
5.1.7 Analysis of genomics datasets 
As a generic rule for any data, the analysis of CNV data generally starts 
with a quality control check of the individual sample-level data. Based on 
the summarized measures of signal intensities (on a log scale), poor 
quality samples are identified and removed from the subsequent analyses. 
For CNV detection, a typical hidden Markov model (HMM)-based CNV 
detection algorithm would require Log R ratio (LRR) and B allele 
frequency (BAF). Both LRR and BAF represent normalized measures of 
total signal intensity and relative allelic signal intensity ratio at each SNP 
respectively 131. Notably, the choice of array technology, algorithms, and 
experimental design largely influence the findings of CNV studies 132. 
Indeed, using a multitude of algorithms for CNV detection would 
minimize the false discoveries 132. 
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In several instances, especially in disease association studies, 
identification of the candidate CNVs for further validation or pursual 
would be the primary interest 133.  Various bioinformatic methods have 
been developed over the last decade for candidate CNV/gene 
prioritization. An unbiased evaluation of such methods has suggested a 
better performance for those tools, which are trained based on already-
known genes, and uses multiple data types in conjunction 134.  
In control population cohorts, functional annotation analyses (e.g, 
overrepresentation of gene ontology terms or KEGG pathways) of the 
genes that fall within CNVs are usually performed using a hypergeometric 
distribution test or Fisher’s exact test-based tools like DAVID 135, 
GeneTrail 136 or Ingenuity pathway analysis suite. However, rare CNVs 
that are typical of a rare disease studies do not hold the assumptions of 
conventional overrepresentation analyses and hence a CNV-enrichment 
test like the one described by Raychaudhuri et al., would be more 
appropriate 137. Notably, the choice of the statistical test and the reference 
database have been known to heavily influence the findings of functional 
annotation analyses 138.  
For gene expression microarray data, the data analysis methods are well 
established and the Bioconductor framework forms a very good tool for 
analysing and integrating data from multiple platforms 139,140. The data 
analysis typically starts with a preprocessing step that includes 
background correction, variance stabilizing transformation and 
normalization 140. For the identification of differentially expressed genes, 
several methods exist that range from a simple t-statistic and ANOVA to 
more advanced linear models 141, SAM 142, and rank product based non-
parametric test statistic 143. Irrespective of the method used for differential 
expression analysis, sorting the differentially expressed genes based on 
both fold-changes and p-values, rather than based on only p-values would 
result in reproducible findings 144.  
After the identification of differentially expressed genes, it would be 
interesting to know the upstream transcription regulators that could have 
mediated the observed changes in gene expression. Such transcription 
factor prediction analyses could be performed both at sequence-level and 
gene-level. Sequence-level predictions check for the enrichment of 
transcription factor binding sites of each known transcription factor in the 
region of interest (e.g, promoter). Gene-level predictions check for the 
enrichment of known target genes of each transcription factor in the set of 
differentially expressed genes. Some useful tools for this task include 
oPOSSUM 145, CENTRIMO 146, HOMER 147 and IPA. Notably, in silico 
prediction of upstream regulators are always suggestive 148 and does not 
necessarily lead to functional validation. The findings should be further 
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guided by the knowledge through some other source (e.g, experimental) 
and one cannot totally rely on the findings of a single tool. For example, 
recently the Encyclopedia of DNA Elements (ENCODE) project has 
accumulated the transcription factor binding information of various 
human cell types under different states 149. The strength of this huge 
resource could be leveraged in conjunction with other public data sources, 
to understand the regulatory mechanisms.  
Genome-wide datasets are increasingly being used to unravel the 
biological networks and pathways underlying complex diseases and traits 
150. To meet this challenge, several statistical methods and platforms have 
been developed over the years to perform biological pathway and network 
analyses 151,152. Ramanan et al., provides a comprehensive overview of the 
concepts and methods for getting started 153. For performing more 
integrative analyses based on the known interactions between and within 
the gene lists of interest, one could use interaction networks that are 
compiled from heterogeneous data sources like protein-protein interaction, 
protein-DNA interaction and other regulatory interactions. For example, 
STRING 154, GENEMANIA 155  and Cytoscape 152 are good tools for such  
tasks. 
5.2 Biological background of music 
5.2.1 Evolution of Music 
Music is universal across all human societies. Nearly 40,000-year-old 
flutes have been discovered recently in archaeological excavations 156. For 
a musical instrument to exist thousands of years ago, music must have 
existed in its advanced form already several years before that 1.The 
rationale for the existence of music has been multifold. Music has been 
seen as a means of communication, and as a source that regulates 
emotions and facilitates cultural enhancement 157–159. Interestingly, the 
auditory centre (the part of the brain that processes sounds) of present-day 
humans function similarly to that of earliest primates that existed millions 
of years ago 160. Likewise, genes related to hearing or deafness have 
evolved convergently in bats and bottlenose dolphins (mammals that use 
sound to locate objects) 161. A similar convergence in amino acid sequence 
evolution has been reported among vocal-learning birds and mammals 162. 
Recently convergent gene expression specializations have been identified 
in both vocal-learning birds and humans in the brain regions that are 
necessary for sound perception and speech production163. Thus, the genes 
that exhibited convergent expression specializations between songbirds 
and humans represent genes belonging to the auditory perception 
pathway. These data point out at a possible hypothesis of evolutionary 
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conservation in the biological processes of sound perception between 
different species.  
5.2.1.1 Innateness of music perception 
The ability to perceive music is substantially characterized by innateness. 
No specific training is required to listen or appreciate music. Recent 
studies on human newborns have established that infants possess abilities 
to detect beats 164, extract pitch independent of timbre 165, process pitch 
intervals 166, detect changes in tonal key 167, distinguish consonance vs 
dissonance, and distinguish minor and major chords 168. Above all, these 
pieces of evidence impart the innateness of music perceptive abilities that 
already appear during the early stages of development in newborns. 
Contradictory hypotheses state that professional expertise in music 
performance can be attained through intense training for more than 10,000 
hours 14. The innateness of musical abilities that comes naturally can be 
considered as nature, whereas the acquisition of further abilities to 
perceive other components of the musical structure can be seen as nurture 
169.   
5.2.2 Neuroscientific studies 
A large abundance of neuroscientific investigations over the last two 
decades has provided novel insights into the effect of music perception 
and training on human brain structure and function. This section reviews 
the landmark neuroscientific studies that provide relevant background 
information for this thesis.  
5.2.2.1 Perception of musical structure 
Music is a multi-dimensional structure comprising of eight main attributes 
namely pitch, rhythm, timbre, tempo, meter, contour, loudness and spatial 
location170,171. Different combinations of these eight attributes give rise to 
different types of music and thus each human culture has a different type 
of music. Initially, it has been thought that music processing is 
predominantly a right-hemisphere activity172, although later it has been 
proved that music processing involves all the regions of the brain173–176. 
Different attributes of music structure like pitch, rhythm, and loudness are 
processed in different regions of the brain and the perceived signals 
conjoin at a later stage to give a holistic picture of the music structure 177–
183. The musical activity associated with different regions of the human 
brain is shown in Table 3. 
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Table 3: Musical activity associated with different regions of the human 
brain (data obtained from Levitin et al., 2009 5) 
Brain region Associated musical activity 
Amygdala Emotional reactions to music 
Auditory cortex The first stages of listening to music; 
The perception and analysis of tones 
Cerebellum Movement, foot tapping, dancing and playing an 
instrument; 
Emotional reactions to music. 
Corpus callosum Connects left and right hemispheres 
Hippocampus Memory for music, musical experiences and 
contexts 
Motor cortex Movement, foot tapping, dancing and playing an 
instrument; 
Nucleus 
accumbens 
Emotional reactions to music 
Prefrontal cortex Creation of expectations;  
Violation and satisfaction of expectations 
Sensory cortex Tactile feedback from playing an instrument and 
dancing 
Visual cortex Reading music, looking at a performer’s movements 
5.2.2.2 Music listening and perception 
Biologically important functions like eating, love, and sex modulates the 
mesolimbic striatal reward system, which leads to a reinforcement 
behaviour to obtain repetitive pleasure 184–189. Likewise, listening to music 
has also been shown to cause intensely pleasurable responses by 
modulating brain regions like ventral striatum, midbrain, amygdala, 
orbitofrontal cortex, and ventral medial prefrontal cortex 16. These brain 
regions are known to be associated with emotion, reward and motivation 
16.  
Certain regions of the brain that are responsible for the locomotory 
behaviors are also activated during music listening 5. Further, listening to 
music has been hypothesized to facilitate neurogenesis by inducing the 
regeneration and repair of cerebral nerves, which is mediated by the 
release of steroid hormones 190. The verbal memory and focused attention 
have improved significantly in stroke patients after listening to music 
when compared to those patients who did not listen to music 191. 
Music-induced reward is further elucidated by the release of dopamine in 
the mesolimbic striatum when experiencing peak emotional arousal 
(pleasure) during music listening 17. The reward value of musical stimuli 
has been shown to be associated with the activity in mesolimbic striatal 
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regions including the nucleus accumbens, which is known to be 
responsible for making predictions and anticipation. Moreover, the 
functional connectivity between the nucleus accumbens and the superior 
temporal gyrus (the region that stores prior information of sounds) has 
increased with increase in reward value, suggesting that the reward 
associated with listening to music may partly depend on the prior musical 
experience of individuals 192. The degree of rewarding aspects of listening 
to music has been shown to depend on the degree of emotional arousal 
associated with listening 193 and the degree of emotional arousal and 
pleasure obtained through listening to music depends on the familiarity to 
an extent 194. 
5.2.2.3 Music education and training 
Music education and training are known to cause functional and 
anatomical changes in the human brain. Because of this reason, the brains 
of professional musicians have been suggested to be an excellent model to 
study neuroplasticity in humans 195.  Indeed, music training has been 
extensively studied as a model for brain plasticity 196. The gray matter 
volume has been found to differ in auditory, motor, and visual-spatial 
regions of professional musicians’ brains when compared to non-
musicians 197. The associative learning involved in music performance 
strengthens the connections between auditory and motor regions of the 
brain and the repeated modulation of this neural network through musical 
training may explain the music performance-induced sensorimotor and 
cognitive enhancements 198. 
Training in music is known to enhance human cognitive abilities. Musical 
training at a young age has enhanced the long-term visual-spatial, verbal 
and mathematical performance 199. Likewise, a school-based instrumental 
training program has significantly enhanced the verbal memory of school 
children 200. Musical experience has been shown to shape the human 
brainstem encoding of linguistic pitch patterns more robustly and 
faithfully when compared to non-musicians, showing a possible link 
between professional musicians’ higher language-learning ability 201. In 
orchestral musicians, musical training altered the structure of Broca’s 
area, which is responsible for sight-reading skills and motor-sequence 
organization that are essential for performing music 202.  
5.2.3 Molecular genetic studies 
The molecular genetic studies of music perception and performance have 
progressed from the earliest familial and twin studies, and conventional 
candidate genes studies to linkage analyses and more recently genome-
wide scans (see Oikkonen 2014 for review13). The individual studies 
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investigated different components of music perception and performance 
including congenital amusia, absolute pitch, musical aptitude, musical 
ability, listening to music, and creativity in music. Amusia refers to the 
disability of discriminating the pitch and time of music. Congenital 
amusia refers to amusia that exists from birth. Absolute pitch (AP) refers 
to a unique ability to recognize and label the musical notes without 
comparing them to a reference pitch and has been known to have a 
complex etiology. 
The earliest evidence for a genetic basis of music perception has been 
obtained through familial and twin studies, which established that musical 
abilities are highly heritable 7–9. The findings of a twin study that studied 
136 monozygotic twin pairs and 148 dizygotic twin pairs demonstrated 
that music perception correlation between twins was 0.67 for monozygotic 
twins and 0.44 for dizygotic twins 7. Peretz et.al 203 have demonstrated 
that congenital amusia arises from defects in processing musical pitch but 
not time, and such musical pitch deficit is highly heritable. 
Pulli et al 10 in a genome-wide linkage scan with 1113 microsatellite 
markers in 15 multigenerational Finnish families (234 individuals) 
revealed a significant linkage on 4q22 with musical aptitude, whereas 
8q13-21 showed a suggestive linkage. In an agreement with the findings 
of Pulli et al, a genome-wide linkage and family-based association 
analysis of musical abilities in Mongolian population11 revealed strongest 
linkage of musical ability on chromosome 4q23. In addition, SNPs in 
UDP glycosyl transferase 8 gene (UGT8; 4q26), a gene that is known be 
involved in brain organization has been shown to be associated with pitch 
perception accuracy. More recently a genome-wide linkage and 
association study of musical aptitude in large multi-generational Finnish 
families 12 showed that genes related to inner ear development and 
neurocognitive functions like GATA binding protein 2 (GATA2; 3q21.3) 
and protocadherin 7 (PCDH7; 4p15.1) are important for musical aptitude. 
A genome-wide linkage study with 6090 SNP markers in 73 multiplex 
families showed a strongest linkage for absolute pitch (AP) on 
chromosome 8q24.21 and several other regions showed suggestive 
linkage with AP 204. It is interesting to note that histone deacetylase 
inhibitors significantly improve the ability to identify pitch 205. 
Candidate gene studies and family-based association analyses have 
demonstrated that both musical aptitude and creativity in music are 
associated with an arginine vasopressin receptor 1A (AVPR1A) haplotype 
206,207, a gene that has been previously known to affect social behavior and 
attachment.  
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6. Aims of the study 
In a broader perspective, the main objective of this thesis is to investigate 
the molecular genetic background of music perception and performance 
using genomics and bioinformatics methods. Specifically this thesis aims 
to 
1. Detect and characterize the CNVs in a Finnish sample set 
characterized for musical aptitude and related traits 
2. Investigate the role of familial and non-familial CNVs in musical 
aptitude and creativity in music 
3. Investigate the effect of listening to classical music on human 
RNA expression profiles 
4. Investigate the effect of music performance on the RNA 
expression profiles of professional musicians 
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7. Materials and methods 
7.1 Study materials and phenotypes 
7.1.1 Ethics statement 
The ethics committee of the Helsinki University Central Hospital 
approved this project (permission #: 233/13/03/2013). An informed, 
written consent was obtained from all the participants. All participants 
were referred with unique identity codes and their names were never used 
during the analyses or reporting. The studies involved no commercial 
interests. 
7.1.2 MUSGEN study material 
MUSGEN project studies the molecular genetic background of musical 
aptitude and related traits208. The MUSGEN study material included large 
multigenerational families and unrelated individuals, who were recruited 
through nation-wide searches. Examples of the study families are shown 
in the previous studies of MUSGEN project 208–211. The initial phase of 
recruitment took place between 2003-2009, where the students and the 
alumni of the Sibelius academy (a university-level music school) and their 
family members, were sent invitations. This led to the recruitment of 
several families that consisted of professional musicians. Later, an 
invitation through newspapers and leaflets led to the recruitment of both 
amateurs and individuals with no music education. Thus, the whole 
MUSGEN study material is characterised by population variation, 
comprising both professional musicians and amateurs. The general 
characteristics of the study material in studies I-IV are shown in Table 4. 
MUSGEN study material originates from the isolated Finnish population. 
The Finnish population is known for its unique genetic landscape. The 
paternally inherited Y chromosome haplotypes and the maternally 
inherited mitochondrial sequences of the Finns exhibit a significant 
decrease in genetic diversity when compared to other European 
populations, suggesting a founder effect 212. The special population history 
of Finland, which is characterized by a very small number of original 
founders, population isolation, and rapid expansion caused the founder 
effect and genetic drift resulting in a unique gene pool 213–215. Previous 
studies have demonstrated the potential of isolated populations in 
searching for rare genetic variants underlying complex traits 216,217. Thus, 
studying the molecular genetic background of complex traits like musical 
aptitude in MUSGEN study material is an added advantage.  
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Table 4: General characteristics of study material in studies I-IV 
Characteristic I II III IV 
Sample size 286 170 & 172 48 20 
Age range (mean) 18-94 
(55.2) 
18-60 18-73 
(42.5) 
23-55 
(43.4) 
Male 119 82 & 71 22 6 
Female 167 88 & 101 26 14 
7.1.3 Phenotypes 
All the participants of the MUSGEN project were characterised for 
musical aptitude and several other music-related traits. Musical aptitude of 
an individual is assessed based on the performance in three tests: the 
Karma music test 218, the Seashore’s tests for pitch and time 219. The 
combined scores (COMB) obtained in the three music tests ranges from 0-
150. Information about the music education of the participants was sought 
through a web-based questionnaire, where the participants had the options 
to choose between 0-3. 0 represents no music education; 1 represents 
music education for less than 2 years; 2 represents music education 
between 2-10 years; and 3 represents professional musicians. The 
participants were also questioned about their abilities to compose, 
improvise or arrange music. The participants who reported possessing any 
of those abilities were considered to have creative abilities in music while 
the remaining were relatively considered to be non-creative. Studies 1, 2 
and 3 used the music-related phenotypes (musical aptitude, music 
education and creativity in music) to analyze the genetic variants and gene 
expression profiles. 
7.2 Laboratory methods 
7.2.1 Genotyping 
Peripheral blood samples were collected from all the participants aged 
above 12, and 200 ng of DNA was assayed on Illumina 
HumanOmniExpress v1 beadchip220 (Illumina Inc, San Diego, CA, USA) 
that contains approximately 730k markers for SNP and CNV analyses. 
Normalized signal intensity data was exported through Illumina 
Beadstudio software (Illumina Inc, San Diego, CA, USA) with an average 
overall call rate of 99.54%.  
7.2.2 Experiment sessions 
In study 3, we investigated the effect of listening to classical music on the 
human transcriptome. For that, we invited around 60 participants from the 
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capital region to participate in a listening session. 48 participants 
volunteered to participate in the study where they listened to Wolfgang 
Amadeus Mozart’s Violin Concerto No. 3 in G major, K.216, which lasts 
20 minutes. All the 48 participants were further invited to attend a control 
session where they do not get exposed to any music. Of them, 15 
participants could attend. The participants were advised to avoid any 
music listening or hard exercising during/before the control session. 
During the control session, the participants were allowed to conversate, 
read a magazine or take a walk outside just as the same duration as in the 
listening session. 
In study 4, we investigated the effect of music performance on the 
transcriptional profiles of professional musicians. A total of 13 
professional instrumentalists of Tapiola Sinfonietta agreed to participate 
in the study, where samples were collected from the participants just 
before and after the performance in a concert for around 2 hours. They 
played five pieces. Ten professional musicians from the Sibelius academy 
participated in the control session, where they were conversating, reading 
a magazine or listening to a lecture for the same duration as the concert 
performance.  
7.2.3 Gene expression profiling 
Peripheral blood samples were collected from the participants just before 
and after the listening session and control session in study 3. Similarly, 
peripheral blood samples were collected from the professional musicians 
just before and after the concert performance and control session in study 
4. In both the studies, peripheral blood was drawn into PAXgene blood 
RNA tubes (PreAnalytix GmbH, Hombrechtikon, Switzerland). RNA was 
isolated using PAXgene blood miRNA tubes (PreAnalytix GmbH, 
Hombrechtikon, Switzerland) and tested for concentration and purity on 
Nanodrop 1000 v 3.7 (Thermo Fisher Scientific, USA). Further, Globin 
mRNA was depleted using Ambion’s Human GLOBINclear kit (Applied 
Biosystems, USA) and tested for RNA integrity on 2100 Bioanalyzer 
(Agilent technologies, Germany). Finally, gene expression profiles were 
assayed using Illumina Human HT-12 V4 beadchip (Illumina Inc; 
Sandiego, CA, USA). 
7.3 Statistical and Bioinformatics analyses 
7.3.1 CNV detection 
The workflow used for CNV analyses in studies I-II is shown in Figure 5. 
All probe coordinates in this study were mapped to human genome build 
GRCh37/hg19. We used two algorithms, QuantiSNP 221 and PennCNV 131 
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to increase the confidence of CNV call and to reduce the number of false 
positives 92,132,222. Both of these algorithms were based on Hidden Markov 
models and use the information on Log2 R ratios and B allele frequencies 
to identify CNVs. Following a stringent quality control criteria at both 
sample-level and CNV-call level as described below, we used only the 
consistent CNV-calls to construct a CNV map. 
7.3.2 Quality control and confirmation 
Samples and their identified CNVs were included in further analyses only 
if they passed the quality control criteria that were defined specifically for 
our datasets, following the software recommendations. The quality control 
criteria are shown in Table 5. A CNV detected by both algorithms was 
merged into a single consistent-call (consensus) by using the outermost 
boundaries defined by either of the algorithm irrespective of their size of 
the overlap. 
Table 5: Quality control criteria to retain samples and the detected CNVs 
Characteristic Value 
Sample call rate 
Log2 R ratio standard deviation 
B allele frequency standard deviation 
Waviness factor 
BAF drift 
Number of detected CNVs per sample 
Length of PennCNV CNVs 
Minimum number of probes within CNV 
Log Bayesian factor of QuantiSNP CNVs 
> 98% 
< 0.15 
< 0.05 
(-0.04, 0.04) 
< 0.002 
< 50 
> 10 bp 
≧ 3 
> 10 
7.3.3 CNV-map construction 
Two different approaches were employed to construct a CNV map, (a) 
conventional copy number variable region (CNVR or CNV-loci) 41 and 
(b) copy number variable cytogenetic region (CNVcR). CNVR or CNV-
loci is an artificial region constructed by the synthesis of overlapping 
CNVs across samples 41. At a given genomic locus, a CNVR could be 
constructed using many different definitions. Nonetheless, the most 
commonly chosen approach in the majority of population-based CNV 
studies59,60,62,65,66,68,92,223–226 is the any-overlap criterion, where the 
boundaries of overlapping CNVs across samples are adjusted based on the 
union of all CNV boundaries at a given locus. We constructed the CNVRs 
separately for deletions and duplications. In order to get a general 
overview of CNVs in the Finnish population, we identified all the 
  31 
cytogenetic regions that contained CNVs and defined them as copy 
number variable cytogenetic regions (CNVcRs). 
 
Figure 5: Overview of CNV analyses workflow used in studies I-II 
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7.3.4 Mining novel CNVRs 
For the identification of novel CNVRs, we directly compared the CNVRs 
detected in this study, with those in the Database of Genomic Variants 
(DGV)227, a database that catalogues CNVs in healthy individuals from 
global populations. Notably, despite the wide adoption of this comparison 
method 59,60,62,65,223,224, it only gives an estimate of novel CNVRs, because 
DGV contains CNVs from many studies differing in array architectures, 
detection methods and population samples. Furthermore, the overlap 
criteria used in these comparisons affect the novelty status of a CNVR. 
Given this, we opted for the ‘no-overlap with any DGV CNVR’ criteria to 
classify a CNVR as novel, thus presenting a lower bound estimate of 
novel CNVRs. Additionally, we compared Finnish CNVRs separately 
with several individual studies 46,60,62,223,228–232 to observe the differences in 
the degree of overlap. 
7.3.5 Statistical analyses 
7.3.5.1 CNV segregation analysis 
We wanted to check if any particular CNV is private to a certain musical 
phenotype. For this, we used the CNV segregation analysis method 
described in Karlsson et al 233. This method ranks each CNV in the 
contrasting phenotype groups of each family (for example: in high COMB 
vs low COMB) based on the observed frequency count. For instance, a 
highly penetrant CNV that appears most frequently in musically creative 
individuals of a family gets a high rank for musical creativity in that 
family.  
7.3.5.2 CNV burden analysis 
CNV burden analysis was performed to check if there was an increased 
burden of CNVs or CNV size in the contrasting musical phenotypes. For 
this, a two-sided Fisher’s exact test was used.  
7.3.5.3 CNV enrichment analysis 
CNV enrichment analysis was performed in both studies 1 and 2. In study 
1, we compared the Finnish CNVs with CNVs from several other 
populations to check if any particular CNVs are enriched or depleted in 
this population. In study 2, we checked if any particular CNV is enriched 
in the opposite musical phenotypes of the unrelated individuals. For this, a 
two-sided Fisher’s exact test was used. All the statistical analyses were 
performed in R. 
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7.3.6 Preprocessing of gene expression data 
The signal intensity data was read into R and preprocessed using the Lumi 
package 234. Lumi package is specifically designed for Illumina arrays. 
The preprocessing included background correction, variance stabilizing 
transformation and quantile normalization. The duplicate and unannotated 
probes are filtered out using the genefilter package235 and the Illumina’s 
detection p-values236 are used to filter out the probes with relatively lower 
intensity compared to the background signal. Probes that were expressed 
in at least half of the arrays were retained for the further analyses.  
7.3.7 Differential expression analysis 
For the identification of differentially expressed genes (DEGs), we used 
the non-parametric method, rank product 143. Implementation of this 
method in R is available in RankProd Bioconductor package 237, which 
allows the users to perform a meta-analysis by combining datasets. Rank 
product offers a powerful method to analyse the datasets that deviate from 
the assumptions of linear models. Instead of using the actual expression 
value, RankProd uses the rank of each gene in each sample based on fold-
changes to identify the consistently up-regulated or down-regulated genes 
across samples. Comparison of fold-changes rather than basal gene 
expression values helps to minimize the effect of other confounding 
factors. For the identification of DEGs, we used a pre-specified criteria of 
percentage of false predictions (pfp) 0.05, fold-change of >1.2, at least a 
pre-post fold-change of 10% in gene expression in the listening session 
(study III), and at least a pre-post fold-change of 15% in gene expression 
in the performance session (study 1V). Although a conservative approach, 
we intentionally increased the stringency in study 1V to restrict the 
number of genes that would be called significantly changed.  
7.3.8 Gene ontology classification and literature survey 
Gene ontology classification was performed using the overrepresentation 
analysis implemented in Genetrail 238. Using a hypergeometric distribution 
test and conservative multiple testing correction method (FDR<0.05), this 
analysis evaluates whether genes involved in certain biological processes 
are enriched in the dataset. In addition, because of the nature of the 
phenotype (less-studied and little molecular evidence in humans), we 
performed extensive literature survey to mine out known biological 
functions of the shortlisted genes. 
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7.3.9 Upstream regulator analysis 
An upstream transcription regulator analysis239 was performed using IPA 
(Ingenuity® Systems, www.ingenuity.com), which essentially predicts all 
the likely upstream regulators based on prior knowledge of known 
interactions between the transcription regulators and DEGs. Using 
Fisher’s exact test, an overlap p-value is computed based on the overlap 
between the known target genes of a transcription regulator and a gene list 
of interest. This analysis also predicts the likely activation state of the 
transcription regulator using an activation Z-score. This prediction is 
based on the literature-derived knowledge of the known direction of 
regulation of the transcription regulators (either activation or inhibition). 
7.3.10 Mining known functional interactions 
The known functional interactions among the DEGs were mined out using 
STRING database 154. STRING database is a collection of all the known 
and predicted protein-protein interactions that are based on multiple lines 
of evidence including high-throughput experiments, co-expression, 
computational predictions, and text mining. Among several protein-
interaction databases, STRING database is one of the largest databases 
that compile data from several interaction-specific databases and other 
model organism-specific multipurpose databases 154.   
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8. Results 
8.1 Detection and characterization of CNVs in the MUSGEN 
cohort 
A total of 5493 CNVs across 267 samples were detected (Illumina SNP 
array; >730k markers) with approximately 70% of them being deletions 
and the remaining being duplications. The size distribution of CNVs is 
shown in Table 6. 
Table 6: Size distribution of consistent CNV calls 
Size bins All CNVs Deletions Duplications 
< 10 kb 2288 (41.7%) 1979(50.9%) 309 (19.2%) 
10 - 50 kb 1831 (33.3%) 1191 (30.6%) 640 (39.9%) 
50 - 100 kb 651 (11.9%) 376 (9.7%) 275 (17.1%) 
100 - 500 kb 668 (12.1%) 328 (8.4%) 340 (21.2%) 
> 500 kb 55 (1.0%) 14 (0.4%) 41 (2.6%) 
The percentages that are shown in the table sum up to 100 vertically. 
CNVs larger than 500 kilobases are thought to be clinically significant 240 
and such large CNV events were detected in ~ 13% of the samples while 
4% of the samples harbored CNVs larger than 1 Mb. However, the sizes 
of CNVs are known to be largely influenced by technology platform 132. 
The general characteristics of the detected CNVs are shown in Table 7. 
Table 7: General characteristics of CNVs in 267 unrelated individuals of 
MUSGEN dataset 
Characteristic Value 
Total CNVs 
Deletions 
Duplications 
Homozygous deletions (%) 
Four-copy duplications (%) 
Average number of CNVs per person 
Average size of CNV per locus (kb) 
Novel CNVRs (%) 
Overlapping RefSeq genes 
Overlapping OMIM genes 
5493 
3888 
1605 
12.4 
0.05 
20 
52.39 
6.9 
835 
396 
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To get a big picture of the CNV landscape in the Finnish population, a 
CNV map was constructed using two criteria; the widely used CNV 
regions (CNVRs) and CNVcRs (based on cytogenetic regions). A total of 
999 CNVRs were characterized and interestingly ~63% of those CNVRs 
contained rare CNVs. Among the 467 cytogenetic regions that contained 
CNVs, the most frequent CNVcRs (Figure 6) were found to be 
significantly overrepresented in Finnish population when compared to 39 
other global populations.  
 
 
Figure 6: Most frequent CNV loci (on the left) and the most frequent genes within 
the CNV loci (on the right) of MUSGEN dataset. On X-axis, the most frequent CNV 
loci or genes are shown. On Y-axis, their relative frequency in the MUSGEN 
dataset is shown. 
 
A study that used Illumina genotyping platform and comprised of ~65% 
Caucasians shared the maximum number of CNVs with this study. 
Several CNVs were found to be enriched and depleted in this population 
when compared to several other global populations (Figure 7).  A total of 
835 RefSeq genes were found to be affected by the CNVs detected in this 
study, of which 396 genes were known to affect inherited diseases or traits 
(OMIM) and 37 genes overlapped novel CNVs. The most commonly 
affected genes among the CNVRs are shown in Figure 6. Gene ontology 
classification revealed the enrichment of terms including sensory 
perception, cognition, neurological system process, cell adhesion, 
molecular transducer activity, alpha-amylase activity and olfactory 
receptor activity.  
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Figure 7: Over- and under-represented CNVs in the isolated Finnish population. 
Enriched and depleted CNVs are shown in different colours as in the figure 
legend.  
 
8.2 Role of CNVs in musical aptitude and related traits 
We followed two different approaches for analyzing the role of CNVs in 
musical aptitude and related traits. First, the family-based approach 
analysed the familial segregation of CNVs in five large multigenerational 
pedigrees. Second, the association analysis was performed in 172 
unrelated individuals (age<=60), who are a subset of the study material 
used in the study I. 
In the family based approach, we used a ranking scheme that ranks each 
CNV in contrasting phenotypes (e.g, high COMB vs low COMB) based 
on the observed frequency count. For example, the CNV that appears the 
most frequent in high COMB individuals of a family is ranked high for 
high COMB within that particular family. Further, we reported only those 
CNVs that were ranked high for a particular phenotype in at least two of 
the studied families. The association analysis in unrelated individuals 
revealed suggestive associations with both musical aptitude and creativity 
in music. However, the p-values did not remain significant after multiple 
chr1
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chr5
chr8
chr10
chr11
chr12
chr13
chr16
chr20
0 Mb 50 Mb 100 Mb 150 Mb 200 Mb 250 Mb
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testing corrections. The CNV loci found in both family-based approach 
and in unrelated individuals are shown in Figure 8. Detailed information 
about the respective loci can be seen in the original article. 
 
Figure 8: CNV loci found to be associated with musical aptitude and creativity in 
music. The loci associated with different music phenotypes are marked with 
distinct colours as shown in the figure legend.  
8.3 Effect of listening to music on human RNA expression 
profiles 
The main objective of study III was to investigate the effect of listening to 
music on the human blood transcriptome. A subset of the MUSGEN 
project participants residing close to the capital region of Finland were 
invited to participate in the study, of which 48 participants volunteered to 
participate in the listening session. Further, 15 of those 48 participants 
attended a control session. The participants listened to a Mozart music 
piece that lasted for 20 minutes and peripheral blood samples were 
collected just before and after listening to music. Similarly, in a control 
session without music exposure, participants chose to either have a 
conversation or take a walk outside and peripheral samples were collected 
just before and after the 20-minute session. The transcriptional responses 
of the participants in both the session were compared to identify the 
chr1
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DEGs. The magnitude of differences in gene expression over time across 
conditions was compared to identify the DEGs. We analyzed the 
transcriptional responses of the contrasting phenotypes (e.g, high COMB 
and low COMB separately). While the musically experienced listeners 
(musically educated and competent listeners) exhibited significant 
differences in gene expression over time compared to control session, the 
inexperienced listeners did not exhibit any significant differences.  
The gene ontology classification and extensive literature survey (as 
described in the methods section) revealed the biological processes 
primarily affected after listening to music (Table 8). The upstream 
regulator analysis using IPA (as described in the methods section) 
suggested that the DEGs significantly overlap the known target genes of 
glucocorticoid receptor NR3C1 (p-value 0.001) and several other 
transcription regulators including TP53, MYC, HOXA9, CD24 and 
chorionic gonadotropins. On the other hand, the down-regulated genes 
were found to be significantly overlapping the known target genes of pro-
inflammatory elements like TNF, IFNG and IFNA2. 
Table 8: Biological processes affected by listening to music 
Biological function Genes Direction  
Secretion, regulation and 
transport of dopamine 
SNCA, RTN4, SLC6A8 Up 
Long-term synaptic potentiation NPTN, SNCA, NRGN, 
FKBP8 
Up 
Dephosphorylation DUSP6, PPP1R12A, 
PPP2CB, SACM1L, 
FKBP1A, and SYNJ1 
Up 
Mitochondrial ATP synthase 
coupled proton transport 
ATP5J, ATP5L Down 
Mammalian neuronal apoptosis, 
cytolysis, caspase, peptidase and 
endopeptidase activity 
CASP8, GZMH, GZMA, 
IFI6, PYCARD, 
TNFRSF10B, and 
HSPE1 
Down 
Song learning and singing in 
songbirds 
SNCA, NRGN, UBE2B, 
RGS2, MYC 
Up 
Associated with absolute pitch FAM49B Up 
Associated with human auditory 
cortex activation 
LRRFIP1, HDAC4 Up 
Regulated by pleasure in 
amygdala 
PPP1R12A Up 
Synaptic vesicular exocytosis, 
endocytosis, neurotransmission, 
synaptic plasticity 
SNCA, NRGN, STXBP2, 
FKBP8, SYNJ1, LYST 
Up 
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8.4 Effect of music performance on human RNA expression 
profiles 
In order to gain insights into the biological basis of music performance, 
study IV investigated the effect of music performance on the 
transcriptional responses of professional musicians. For this, the 
transcriptional responses of professional musicians in response to a 
concert performance session and a control session were compared. The 
magnitude of pre-post changes in gene expression over time across 
conditions was compared. 13 professional musicians belonging to Tapiola 
sinfonietta, an orchestra of instrumentalists volunteered to participate in 
the study. 
Those 13 professional musicians were performing five music pieces in a 
public concert that lasted for around 2 hours. Of the 13 participants, 
samples from 10 participants were found eligible for the analyses. In a 
control session that lasted for the same duration as the performance 
session, the participants were either voluntarily listening to a lecture or 
taking a walk outside.  Peripheral blood samples were collected from the 
participants just before and after the performance and control sessions. 
Rank product non-parametric statistics and stringent selection criteria 
identified 73 DEGs. 
The DEGs affected several biological processes primarily related to the 
cognitive mechanisms and neurotransmission. The affected biological 
functions based on gene ontology classification and literature survey (as 
described in the methods section) are summarized in Table 9.  
An upstream regulator analysis using IPA (as described in the methods 
section) predicted that the up-regulated genes significantly overlapped the 
known target genes of transcription factor GATA1 (p-value 0.000003; Z-
score 2.000), cytokines CCL5 and TNFSF11, and insulin-like growth-
factor IGF1. On the other hand, down-regulated genes significantly 
overlapped the known target genes of pro-inflammatory elements such as 
IL2 and IL15. Based on prior knowledge that GATA transcription factors 
GATA1 and GATA2 regulate SNCA gene and its coexpression network 241, 
we checked and found out that 27.5% of the co-expression network 
molecules are differentially expressed along with SNCA, which 
complements the findings of upstream regulator analysis that GATA1 
could be a potential upstream regulator of music performance-induced 
transcriptional changes. Further, a functional interaction analysis using 
STRING database revealed a significant functional network with a 6.37-
fold increased interactions (p-value: 1.77x10-14). 
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Table 9: Biological processes affected by music performance in professional 
musicians 
Biological functions Genes 
Song perception and 
production in songbirds 
SNCA, FOS, DUSP1, ZNF223, ARHGAP26, 
PLAUR, SELENBP1, FTH1, SRXN1, ASCC 
Uptake, transport, 
regulation of 
neurotransmitters 
CLN8, SNCA 
Catecholamine 
biosynthetic process 
HDC, SNCA 
Elevation of cytosolic 
calcium ion concentration 
CCR4, CD24, SNCA 
Motor behavior CCR4, CLN8, PLAUR, FOS, SNCA 
Dopamine neuronal 
homeostasis 
SNCA, FBXO7, PIP4K2A, PPP2R3A 
Synaptic plasticity SNCA, FOS, CLN8, PIP4K2A 
Learning, memory and 
cognitive functions 
FOS, HDC, CLN8, FTH1, DOPEY2 
Neurotransmission DUSP1, FBXO7, PPP2R3A 
Neurite outgrowth and 
neurogenesis 
CD24, SELENBP1 
Neuronal differentiation PLAUR, CLN8 
Neuronal activity SLC4A1, SLC4A5, HIST2H2BE 
Calcium ion homeostasis FOS, CLN8, MYL4 
Speech and language DOPEY2, RNF213, ANKRD44 
Glutathione metabolism ODC1, PIP4K2A 
Neuropsychiatric and 
neurodegenerative diseases 
SNCA, FOS, ARHGAP26, HDC, CLN8, 
SELENBP1, FTH1, ADIPOR1, FBXO7, 
PIP4K2A, SRXN1, DOPEY2, GMPR, 
RNF21 
Cellular iron ion 
homeostasis 
FTH1, ALAS2 
Hemoglobin metabolic 
process 
AHSP, ALAS2 
Associative learning CLN8, FOS 
cAMP-response elements DUSP1, FOS 
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9. Discussion 
9.1 Genome-wide architecture of CNVs in musical traits 
The detection and characterization of CNVs in the MUSGEN sample set 
led to the identification of certain enriched and depleted CNVRs, which is 
characteristic of a founder population. In addition, an increased rate of 
common CNVs and homozygous deletions in this sample set 
demonstrated a founder effect. A similar trend has been observed earlier 
in a CNV study of three other population isolates (island of Vis in Croatia, 
islands of Orkney in Scotland, and the south Tyrol in Italy)242.  
Intrigued by the enrichment of several CNVs, we checked whether those 
CNVs were associated with musical phenotypes; we found no statistically 
significant hits owing to the ‘less-powered’ sample set. Nevertheless, we 
cannot exclude the possible role of some of the enriched CNVs in musical 
aptitude and related traits because of their remarkable relevance for brain 
functions. In fact, in a different approach (in family-based analysis of 
CNVs in study II), some of those enriched CNVs (containing genes like 
PCDHA1-9 and GALM) were found to be co-segregating with various 
musical traits.  
Most importantly, a duplication at 2p22.1 covering GALM gene was found 
to be co-segregated with creativity in music in study II. By altering the 
regional neurophysiology, GALM gene has been suggested to increase the 
local serotonin concentration and membrane trafficking of the serotonin 
transporter in the human thalamus, thus affecting the serotonergic 
neurotransmission 243. Interestingly, creativity, in general, has also been 
known to be associated with a serotonergic gene, TPH1 244, which 
suggests that creativity in music is analogous to creativity, in general. In 
addition, enhanced serotonergic neurotransmission has been shown to 
improve awareness and thinking, the key components of general creativity 
245. Serotonin transporter gene (SLC6A4) has also been shown to be 
associated with other forms of creativity like creativity in dance 246 and 
verbal and figural creativity 247. This supports the importance of 
serotonergic pathways in human creativeness. 
Further, we found a deletion at 5q31.1 covering protocadherin alpha gene 
cluster (PCDHA1-9) that co-segregated with a lower musical aptitude 
(low music test scores). The gene cluster has been shown to be essential 
for the appropriate serotonergic innervation 248,249, which when disturbed 
leads to abnormalities in behaviors and neuropsychiatric conditions. 
Moreover, this gene cluster has also been known to be necessary for 
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neuronal development and survival 250. Interestingly, another gene 
belonging to the protocadherin family, PCDH15, has been found to be 
evolutionarily conserved in echolocating bats and dolphins based on 
convergent sequence evolution analysis 161. Another gene belonging to the 
same gene cluster, PCDH7, was shown to be associated with musical 
aptitude in humans based on genome-wide linkage analysis 12. These 
protocadherin genes are known to be responsible for auditory 
development and hearing 12.  
Another CNV enriched in the sample of study I contained the PRKG1 
gene, which is known to express abundantly in the amygdala, the center 
for emotional reactions to music. The PRKG1 gene has been shown to 
regulate long-term potentiation, the biological process that has repeatedly 
been shown to be enhanced by training in music 251. 
Although, some of the detected CNVs were relevant for neuropsychiatric 
diseases (e.g, CNVs covering DLGAP2, MCTP2, MYO6, SEN6, INTS4L1, 
ZNF92 and EXOC4), while interpreting the findings, one should 
remember that the study material was not screened for neuropsychiatric 
illnesses. However, some examples suggest that the interaction between 
gene expression and environmental exposure determine the development 
of certain neuropsychiatric disorders 252,253.  
Our findings also suggested that the burden of large or rare CNVs do not 
have an impact on musical aptitude and related traits. Interestingly, CNV 
studies, in general cognitive abilities (analogous to musical aptitude), have 
shown that rare mutational load does not affect childhood- or late-life 
cognitive abilities 254 and only common variants explain the majority of 
heritability for intelligence and language abilities 255–257. This suggests that 
large and rare CNVs may spare the biological pathways that affect normal 
cognitive traits. 
Overall, our CNV studies presented a unique resource of CNV map from 
normal individuals, representing a population isolate. There has been a 
dearth of comprehensive CNV map from the Finnish population, and also 
from isolated populations, in general. Moreover, familial CNV data and 
CNV studies in normal traits have also been scarce.  
9.2 Effect of listening to music and performing music on 
human transcriptome 
Most importantly, music-listening resulted in the up-regulation of genes 
involved in dopaminergic neurotransmission (SNCA, RTN4, SLC6A8), 
which is consistent with the findings of a human PET study that 
demonstrated the endogenous release of dopamine during peak emotional 
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arousal in music listening 17. Interestingly, music performance also 
resulted in the up-regulation of genes related to dopamine neuronal 
homeostasis (SNCA, FBXO7, PIP4K2A, PPP2R3A). This suggests that 
both music listening and performance modulate dopaminergic pathways. 
Here it is important to note that professional musicians in a concert 
actively listen to music from the fellow musicians to maintain a 
synchrony. In addition, genes related to synaptic vesicular exocytosis and 
endocytosis (STXBP2, SYNJ1, LYST, SUMO2, HDAC4, DUSP6), which 
are crucial for dopamine secretion and re-uptake 258,259 were also up-
regulated, thus revealing the molecular mechanisms involved in music-
induced dopaminergic functions.  
In general, cognitive abilities like learning and memory are essential for 
music perception and performance. Some of the genes up-regulated after 
music listening (SNCA, RTN4, NRGN, NPTN FKBP8 and HDAC4) and 
music performance (FOS, HDC, CLN8, FTH1, DOPEY2) were known to 
enhance learning and memory. Interestingly, murine genomics studies 260 
and abundant neuroscientific literature 200,202,261 have suggested that music 
exposure enhances cognitive abilities like learning and memory. The up-
regulation of motor behavior-related genes (CCR4, CLN8, PLAUR, FOS, 
SNCA) by music performance only, but not by music listening points out 
at the host of multisensory motor skills that are required during music 
performance 261,262. As dopaminergic neurotransmission plays a crucial 
role in the regulation of learning and memory, and motor control 263, we 
can speculate that dopaminergic pathways act upstream of all the music-
induced biological processes.   
Music performance has also resulted in the up-regulation of genes that 
elevate the cytosolic calcium ion concentration. Interestingly, auditory 
cortex stimulation is known to elevate the outer hair cell calcium ion 
concentrations 264, which in turn regulates the neurotransmitter release 265, 
synaptic transmission 266, activity-dependent synaptic plasticity 267, and 
downstream gene expression 268. In songbirds, intracellular calcium ion 
concentration is known to regulate the neuronal firing pattern, which is 
responsible for the song control system 269.  
Several genes that are known to cause neurodegenerative and 
neuropsychiatric conditions when disrupted (SNCA, FOS, ARHGAP26, 
HDC, CLN8, SELENBP1, FTH1, ADIPOR1, FBXO7, PIP4K2A, SRXN1, 
DOPEY2, GMPR, RNF213), were up-regulated after music performance, 
whereas some genes that cause neurodegeneration were down-regulated 
after music listening (CASP8, GZMH, GZMA, ATP5J and ATP5L). It is 
well known that music is widely used as a therapeutic tool in clinical 
settings, especially during the treatment of neurodevelopmental and 
neurodegenerative diseases (AMTA, 2014.; Conrad, 2010). For example, 
  45 
music is known to enhance cognitive recovery and mood, and reduce 
anxiety and depression in patients with impaired brain functions 191,272–274. 
Our findings suggest a possible neuroprotective role of music listening 
and performance, and may explain the molecular mechanisms of music 
therapy in neurodegenerative diseases.  
9.2.1 Striking findings 
Most remarkably, both music listening and music performance enhanced 
the activity of several genes that are known to be involved in the song 
perception and production processes of songbirds (e.g, SNCA, NRGN, 
RGS2, UBE2B and AHAS2 after music listening and SNCA, FOS, DUSP1, 
ZNF223, ARHGAP26, PLAUR, SELENBP1, FTH1, SRXN1 and ASCC2 
after music performance) 275, which suggests a possible evolutionary 
conservation of biological processes related to sound perception. In 
addition, genes that exhibited convergent gene expression specializations 
between songbirds and humans163 in the regions of brain that are 
necessary for sound perception and speech production were found to be 
enriched among the DEGs after listening to music and music 
performance. Further, several of the genes that were differentially 
expressed after music performance were reported to be regulated by 
singing in songbirds 276. These findings are consistent with the 
evolutionary conservation of genes related to auditory processes and 
hearing in echolocating bats and dolphins 161. 
No significant transcriptional responses were observed after listening to 
music in the musically inexperienced participants (no music education, 
low music test scores). Although surprising, based on the prior 
knowledge, we speculate that musical experience 206, the familiarity of the 
music 277 and personal liking of the music 191 could have mediated this 
finding.  
9.2.2 Music listening vs Music performance 
Notably, SNCA (4q22.1; up-regulated after both music listening and 
performance) and its upstream transcription regulator GATA2 241  
(3q21.1), are located in the most significant regions of linkage and 
association with musical aptitude 10,12, thus demonstrating convergent 
evidence from both gene expression studies and genome-wide association 
studies.  
Few genes that were down-regulated after music listening (ZNF223 and 
PPP2R3A) were up-regulated after music performance. Most importantly, 
ZNF223 is a C2H2 type zinc-finger containing transcription regulator, 
which is similar to an immediate early response gene (IEG) ZNF225 (also 
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known as ZENK, EGR1). A plethora of evidence suggests a regulatory 
role for ZNF225 in the song control system of songbirds. Besides, 
PPP2R3A gene, which is highly expressed in the striatum, is known to 
integrate the effects of dopamine and other neurotransmitters. Notably, 
ZNF225 gene has been strikingly up-regulated during the act of singing, 
but not hearing a song in the song control nuclei of songbirds. On the 
contrary, hearing a song but not singing, induces ZNF225 expression in 
parts of the songbirds’ forebrain. Interestingly, IEGs such as FOS and 
DUSP1 that are known to be responsible for song control nuclei of 
songbirds were up-regulated only after music performance, but not music 
listening. On the other hand, IEGs and several other song perception-
related genes in songbirds like NRGN, RGS2, UBE2B, LRRFIP1, 
FAM49B, HDAC4, KLF4 and MYC were found to be differentially 
regulated after music listening, but not music performance.  
9.3 Methodological and statistical issues 
9.3.1 Arrays 
In both the CNV studies, the study material was genotyped on an Illumina 
SNP array (Human OmniExpress) that has a marker resolution of ~ 
733,202 markers for SNP and CNV detection. This array is one of the few 
SNP arrays that targets CNVs detected in previous studies 132. Such CNV-
enriched arrays have been shown to detect more CNVs and have more 
reproducibility 132. Although a direct comparison of the commercially 
available SNP arrays is not appropriate 278, their performance in 
diagnostics is often comparable 279,280. However, arrays with a better 
resolution perform better in the detection of smaller CNVs and estimation 
of breakpoints 132. Compared to SNP arrays, the latest NGS-based 
methods perform even better in the detection of smaller CNVs (in a 
resolution of tens of bases) and in precise estimation of breakpoints (at a 
single base resolution) 281. However, reliable calling of CNVs from NGS 
data requires sequencing of the genome at a coverage ≧ 20x, which is 
expensive when compared to the cost of SNP arrays 281. 
In both the transcriptomic studies, the gene expression profiling was 
carried out on a Illumina gene expression array (Human HT-12) that 
targets more than 47k probes. Although the findings of MAQC project 282 
suggested a high level of concordance between different commercial 
expression microarrays, other factors such as input RNA requirement, 
usability, technical performance, and especially the cost of Illumina 
expression beadchip kits allow the expansion of experimental design. 
Several recent studies have compared microarray and the latest RNAseq 
technologies particularly concerning detection of the DEGs, absolute 
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expression levels and technical reproducibility 121,127,283,284. Although the 
correlation between gene expression profiles of microarrays and RNAseq 
has been good (>0.80 across several studies), the latter has been suggested 
to be more sensitive in identifying DEGs, especially genes with low 
expression levels and more accurate in estimating the absolute expression 
levels 127,128. Also, unlike the exon array vs exome sequencing, the costs 
associated with gene expression profiling using microarrays and RNAseq 
are comparable these days. However, microarrays are still time-effective 
and cost-effective in terms of data storage and analysis. Because of this 
reason, microarrays still remain useful to measure known targets in large 
samples.  
9.3.2 Algorithms 
Two HMM-based algorithms PennCNV 131 and QuantiSNP 221 were used 
to detect the CNVs in studies I-II, and only the consistent calls between 
both algorithms (~ 65% concordance) were retained for further analyses.  
Both PennCNV and QuantiSNP are specifically developed for Illumina-
based SNP arrays. A comprehensive assessment of CNV detection 
algorithms 132 demonstrated a better performance of platform-specific 
algorithms. Also, using a multitude of algorithms for CNV detection has 
been shown to reduce false-discoveries 132. CNV studies, in general, suffer 
from the lack of standardized practices in the detection and reporting 285. 
Based on our own experience, there exists a lack of consensus opinion in 
the scientific community about handling the CNV calls. For example, 
there are no standard principles for merging adjacent CNVs, constructing 
CNV regions, checking the consistency of a CNV call between 
algorithms, and mining novel CNVs, which makes the comparison of 
CNVs between studies challenging. Because of this reason, we chose to 
follow widely adopted methods in our CNV detection methodology.  
For the selection of DEGs in transcriptomics studies, algorithms like 
empirical Bayes (from limma), SAM, and rank product are widely used. 
The distribution, homogeneity, and the sample size of the data influence 
the choice of an appropriate algorithm. In both the transcriptomics studies, 
we chose to use rank product non-parametric statistic 143 because of 
several reasons. First, a random visualization of transcriptional responses 
over time across conditions appeared to deviate from normality. Second, 
because of the nature of the phenotype there is a possibility for the 
transcriptional responses to be non-homogenous in some instances. Third, 
the sample sizes in each comparison group were small (around 10). Rank 
product non-parametric statistic has been shown to have better 
performance than empirical Bayes statistic and SAM when the sample 
sizes are small and when the data deviates from normality and 
homogeneity 286. A performance evaluation of eight commonly used gene 
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selection algorithms on a gold-standard dataset (MAQC) has 
demonstrated the high sensitivity and specificity of rank product method 
287.   
9.3.3 Experimental setting and validity of the findings 
The molecular genetic background of musical traits (including musical 
aptitude) is largely unknown. Prior knowledge suggests that musical traits 
are multifactorial, caused by both predisposing genes and an exposure to a 
musically rich environment 13. Among the many contributing genes, some 
of the alleles might be rare and have a strong effect while the others can 
be common and have a small effect. Large families with enriched musical 
phenotypes are especially suitable for the identification of major alleles 
with large effect. Families also provide a suitable study setting when no 
common founder mutation in a gene is present in the study population, 
thus allowing the study of different mutations in different families. A 
case-control study setting is usually used for the identification of alleles 
with small effect, as exemplified in other normal traits like height 288 and 
intelligence 75. Here, we analyzed the role of CNVs in musical traits using 
both familial and case-control settings.  
One of the primary strengths of the studies I-1V is the unique study 
material that contains both amateurs and professional musicians, the 
majority of whom were characterized for musical aptitude and related 
traits. Although samples from isolated populations have been included in 
larger CNV studies, there was only one CNV map that compiled CNVs 
from three European population isolates (island of Vis, islands of Orkney, 
south Tyrol) based on a much smaller marker resolution (~300k 
markers)242. CNVs have been heavily implicated in neurodevelopmental 
and neurodegenerative diseases, but only a few studies investigated the 
role of CNVs in normal cognitive traits 289,290. Although some of the 
previous CNV studies contained family-based study setting 291, to our 
knowledge, no previous study analyzed the CNV inheritance pattern in 
several large multigenerational families.  
One of the major shortcomings of the case-control setting in study II is the 
small sample size, which certainly affected the statistical power to detect 
potential association of CNVs with the phenotype of interest. Low 
statistical power not only hinders the possibility of finding a true effect, 
but also reduces the likelihood of a claimed true effect to be true 292. 
Although the sample size of the Finnish population-based CNV study is 
comparable to some of the contemporary population-based CNV studies 
58,62,228, bigger sample size would definitely give a better estimate of the 
CNV frequencies. In transcriptomics studies, although the participants 
were broadly categorized into different phenotype groups (for example, 
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musically experienced and inexperienced participants), there existed 
several other factors, which could influence the individual variation in 
transcriptional responses. For example, personal liking of the music genre 
is another categorical variable that influences the transcriptional 
responses. Therefore, recruitment of a homogenous set of participants is 
essential to reduce the individual variation in transcriptional responses. 
Also, randomization of the participants across experiment and control 
groups would reduce a potential bias.  
Approximately 93% of the CNVs detected in study I were already known 
(catalogued in DGV 227), which suggests that the performance of CNV 
detection methodology used in studies I-II is on par with published CNV 
studies 66,226,232.  In study II, we detected suggestive association of certain 
CNVs with the phenotype of interest, where the p-values did not stand 
multiple-testing correction. These findings have to be interpreted with 
caution and a replication study with adequate sample size is warranted. 
Additionally, some of the CNVs that were found to be associated with 
musical traits in both familial and case-control setting in study II were 
also found with increased frequency in MUSGEN sample set of 267 
subjects analyzed in study I. Although the study material of study I 
represent the normal population of Finland, they were essentially selected 
and characterized for musical traits. Therefore, from these studies it was 
challenging to conclude whether the enrichment of CNVs was because of 
the phenotype or the population. Comparison of CNV frequencies from a 
different Finnish population-based dataset might reveal further insights.  
In both the transcriptomics studies, we used appropriate statistical 
methods to analyze the data after careful examination of the datasets. 
Being aware of the inherent noisy nature of microarrays, additional 
validations are certainly necessary to increase the confidence of the 
findings. But, we did not have a sufficient quantity of RNA samples to 
perform further experimental validations like qPCR. In the absence of 
experimental validation, we wanted to see how the DEGs in both the 
transcriptomic studies fit with the previous findings of music perception 
and performance. In humans, no gene expression data exists concerning 
music perception and performance. But there are perfect animal models, 
songbirds, whose song learning and singing involve auditory perception 
and motor behavior. Genes that exhibited convergent gene expression 
specializations between songbirds and humans163 in the regions of brain 
that are necessary for sound perception and speech production were found 
to be enriched among the genes that are differentially expressed after 
listening to music and music performance. Further, several of the genes 
that were differentially expressed after music performance were reported 
to be regulated by singing in songbirds 276. These findings added 
additional strength to our findings. However again, replication studies are 
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certainly necessary to confirm these findings. Another aspect of the both 
the transcriptomics studies is the modest fold-changes. Fold-change 
thresholds, in general, are chosen arbitrarily and they largely depend on 
the underlying biological question, the nature of the treatment and the 
sample size. We used fold-change thresholds similarly as in previous 
studies of gene-environmental interactions 293,294.  
One more topic of debate about the transcriptomic studies is the usage of 
peripheral blood samples as a proxy for brain tissue. There has been a 
consensus opinion that brain tissue share up to 80% of the transcriptome 
with peripheral samples 295–298. Physiological stimuli-responsive genes, 
genes involved in neuroendocrine pathways are known to mirror their 
expression in peripheral blood. For example, potential hallmarks of 
Parkinson’s disease (altered dopamine metabolism and mitochondrial 
dysfunction) are reflected in peripheral blood transcriptome 299. Owing to 
all these reasons, peripheral blood has been used earlier in several studies 
as a proxy for brain tissue, especially in humans, as brain tissue is 
inaccessible. 
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10. Conclusions and future prospects 
10.1 Future prospects 
Future experimental designs in this field should leverage the strengths of 
both microarrays and state-of-the-art NGS technologies. As the price of 
RNAseq is now comparable to that of microarrays, it would be beneficial 
to use RNAseq, as it also allows the study of rare transcripts, splice 
variants and fusion transcripts. To increase reliability and reproducibility 
of the findings, it is essential to have adequate statistical power. 
Therefore, statistical power calculations and sample size determinations 
are necessary before performing future experiments. The selection of 
study participants should also be given due importance. More insights can 
be obtained by studying participants of extremely contrasting phenotypes. 
In transcriptomics studies, recruitment of homogenous set of participants 
would reduce the individual variation in transcriptional responses. Also, 
randomization of participants across treatment and control conditions or 
retaining the pairing of samples in both treatment and control conditions 
may reduce potential biases. Future studies may look to understand the 
effect of different genres of music and different instruments. Studying all 
these effects in global populations would help to generalize the findings. It 
would also be interesting to study the changes in transcriptional responses 
on a temporal scale by obtaining samples at multiple time points. Previous 
studies have reported several physiological markers associated with 
listening to music including variations in blood pressure, heart rate, serum 
melatonin levels, stress response biomarkers, mood and cognitive 
performance 3.  Future studies may benefit by profiling some of these 
biomarkers to help in the interpretation of findings. Future studies should 
replicate and confirm these findings. Also, genes of primary interest could 
be verified in animal models. Obtaining multiple lines of evidence using 
different data types (DNA, RNA, miRNA, methylation etc) may help in 
the comprehensive identification of pathways associated with the 
phenotype of interest.   
One of the common traits of genomics studies is the production of huge 
lists of genes. But only a subset of those genes is of real interest. To 
prioritize such top candidate genes in the phenotype of interest, it would 
be beneficial to develop a bayesian framework to integrate the findings 
from multiple lines of evidence (human GWAS, CNV, RNA, miRNA, 
protein, ChIPSeq, methylation and data from animal models). The gene 
that is found across the maximum number of independent lines of 
evidence gets the maximum score. A convergence in the biological 
mechanisms of musical traits has already been evident through our 
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findings, where SNCA gene was implied in listening to music, music 
performance, musical aptitude and song control system in songbirds. 
10.2 Conclusions 
By leveraging the strengths of genomics approaches, this thesis enters an 
unexplored territory so far: the molecular determinants and mechanisms 
underlying music listening and performance. Both the CNV and gene 
expression studies revealed that the molecules associated with music 
perception and performance are linked to biological processes like 
neurodevelopment, learning, memory, dopaminergic neurotransmission, 
neurodegeneration, song learning and singing. To date, neuroscientific 
literature has provided substantial evidence concerning the 
neuroanatomical and physiological changes associated with music 
perception and performance. But this study presented a set of candidate 
genes that could have a role in music perception and performance. While 
the findings cannot be generalized to different ethnic groups and different 
genres of music, these pioneering findings could guide further research in 
the molecular genetics of music perception and performance. These 
findings will also enhance our understanding of the genetic bases of 
cognitive traits, the evolution of music, and music therapy.  
In general, listening and practicing music gives an intense feeling of 
happiness. The genes involved in mediating such euphoria-like feeling 
could also cause the opposite state of feelings like depression and mood 
disorders when affected by genomic variation or gene-environment 
interaction. Therefore, studies like these may also serve a purpose to 
identify novel candidate genes for neuropsychiatric diseases. After all, 
such studies may enhance our everyday life because of the immense social 
relevance. 
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